Parkinson’s Syndrome Articles
Eighty-One Patients with Multiple Sclerosis and Parkinson’s Disease Undergoing Upper Cervical Chiropractic Care to Correct Vertebral Subluxation: A Retrospective Analysis
Elster EL Journal of Vertebral Subluxation Research August 2, 2004, pp 1-9 Objective: The objective of this article is threefold: to examine the role of head and neck trauma as a contributing factor to the onset of Multiple Sclerosis (MS) and Parkinson’s disease...
Olfaction and Parkinson’s syndromes: its role in differential diagnosis
Katzenschlager R, Lees AJ Curr Opin Neurol 2004 Aug;17(4):417-23 The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK. PURPOSE OF REVIEW: Marked olfactory dysfunction (hyposmia) is a frequent and early abnormality in Parkinson’s disease. We...
Effect of One Single Auditory Cue on Movement Kinematics in Patients with Parkinson’s Disease
Ma, H-I.; Trombly, C.A.; Tickle-Degnen, L.; Wagenaar, R.C. American Journal of Physical Medicine 2004 Jul; 83(7): 530-6 ABSTRACT: Objective: The purpose of this study was to determine whether one single auditory cue affected movement kinematics of more than one...
Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men
Leyton M, Dagher A, Boileau I, Casey K, Baker GB, Diksic M, Gunn R, Young SN, Benkelfat C Neuropsychopharmacology 2004 Feb;29(2):427-32 Department of Psychiatry, McGill University, Montreal, Quebec, Canada. Acute phenylalanine/tyrosine depletion (APTD) has been...
Traditional Chinese medicine in treatment of Parkinson’s disease[Article in Chinese]
Zhang QJ, Zhang YY, Huang WY Zhong Xi Yi Jie He Xue Bao 2004 Jan;2(1):75-7 Institute of Cardio-cerebrovascular Disease, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437,...
Plasma levels of mediator amino acids in patients with Parkinson disease[Article in Russian]
Vitreshchak TV, Poleshchuk VV, Piradov MA Biomed Khim 2004 Jan-Feb;50(1):92-9 Institute of Neurology, Russian Academy of Medical Sciences, Volokolamskoe Shosse 80, 125367 Moscow, Russia. Content of neurotransmitter amino acids before and after treatment with...
The Treatment of Parkinson’s Disease By Acupuncture and Herbal Medicine
Xue, Y The Journal of Chinese Medicine 2003 Oct ; 73 ABSTRACT: This article discusses the aetiology and pathology of Parkinson’s disease, its pattern identification according to Chinese medicine, and its treatment by body acupuncture, scalp acupuncture, pricking to...
Reduction of brain dopamine concentration with dietary tyrosine plus phenylalanine depletion: an [11C]raclopride PET study
Montgomery AJ, McTavish SF, Cowen PJ, Grasby PM Am J Psychiatry 2003 Oct;160(10):1887-9 Imperial College, School of Medicine, University Department of Psychiatry, Warneford Hospital, Oxford, UK. OBJECTIVE: Extracellular dopamine concentrations were estimated through...
Coenzyme Q10 in neurodegenerative diseases
Shults CW Curr Med Chem 2003 Oct;10(19):1917-21 Department of Neurosciences, University of California, San Diego, LaJolla, CA 92093-0662, USA Coenzyme Q(10) (ubiquinone), which serves as the electron acceptor for complexes I and II of the mitochondrial electron...
Deep brain stimulation for Parkinson’s disease
Panikar, D.; Kishore, A Neurology India 2003 Apr ; 51(2): 167-75 ABSTRACT: Dopaminerigic replacement therapy with levodopa/carbidopais still the cornerstone for the treatment of Parkinson’s disease (PD). However, the medical management of PD is complicated by the...